TA-MSCs、TA-MSCs-EVs、MIF:它们在免疫抑制性肿瘤微环境中的相互作用。
TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment.
机构信息
Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
Department of Orthopedics, The Fourth Affiliated Hospital of China Medical University, Shenyang, China.
出版信息
J Transl Med. 2022 Jul 16;20(1):320. doi: 10.1186/s12967-022-03528-y.
As an important component of the immunosuppressive tumor microenvironment (TME), it has been established that mesenchymal stem cells (MSCs) promote the progression of tumor cells. MSCs can directly promote the proliferation, migration, and invasion of tumor cells via cytokines and chemokines, as well as promote tumor progression by regulating the functions of anti-tumor immune and immunosuppressive cells. MSCs-derived extracellular vesicles (MSCs-EVs) contain part of the plasma membrane and signaling factors from MSCs; therefore, they display similar effects on tumors in the immunosuppressive TME. The tumor-promoting role of macrophage migration inhibitory factor (MIF) in the immunosuppressive TME has also been revealed. Interestingly, MIF exerts similar effects to those of MSCs in the immunosuppressive TME. In this review, we summarized the main effects and related mechanisms of tumor-associated MSCs (TA-MSCs), TA-MSCs-EVs, and MIF on tumors, and described their relationships. On this basis, we hypothesized that TA-MSCs-EVs, the MIF axis, and TA-MSCs form a positive feedback loop with tumor cells, influencing the occurrence and development of tumors. The functions of these three factors in the TME may undergo dynamic changes with tumor growth and continuously affect tumor development. This provides a new idea for the targeted treatment of tumors with EVs carrying MIF inhibitors.
作为免疫抑制性肿瘤微环境(TME)的重要组成部分,间充质干细胞(MSCs)促进肿瘤细胞的进展已得到证实。MSCs 可以通过细胞因子和趋化因子直接促进肿瘤细胞的增殖、迁移和侵袭,并通过调节抗肿瘤免疫和免疫抑制细胞的功能促进肿瘤进展。MSCs 衍生的细胞外囊泡(MSCs-EVs)包含 MSCs 部分质膜和信号因子;因此,它们在免疫抑制性 TME 中对肿瘤显示出相似的作用。巨噬细胞移动抑制因子(MIF)在免疫抑制性 TME 中促进肿瘤的作用也已被揭示。有趣的是,MIF 在免疫抑制性 TME 中发挥的作用与 MSCs 相似。在这篇综述中,我们总结了肿瘤相关 MSCs(TA-MSCs)、TA-MSCs-EVs 和 MIF 对肿瘤的主要作用和相关机制,并描述了它们之间的关系。在此基础上,我们假设 TA-MSCs-EVs、MIF 轴和 TA-MSCs 与肿瘤细胞形成正反馈回路,影响肿瘤的发生和发展。这三个因素在 TME 中的功能可能随着肿瘤的生长而发生动态变化,并不断影响肿瘤的发展。这为携带 MIF 抑制剂的 EV 靶向治疗肿瘤提供了一个新的思路。